Integrated Biofield Modulation to Reduce Cellular Metastasis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments are toxic to patients, do not restore non-cancerous states, and are limited in biological scope, often leading to treatment resistance and failing to address metastasis effectively.
Innovation Solution
Systems and methods that induce biophysical, structural, and physiological changes in cells using biofield therapy, altering gene expression and cellular features to reduce metastatic potential and tumor growth, including changes in bioelectrical features, cytoskeleton organization, and energy metabolism.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current approved cancer treatments are used, then cancer cells are targeted and killed, but the treatments are toxic to patients and do not restore non-cancerous states
Solution Approach 1:
The patent applies parameter changes by modulating biophysical parameters (membrane potential, ion channel activity), structural parameters (cytoskeleton organization), and physiological parameters (gene expression, metabolism) of cells to distinguish and treat cancer cells while preserving healthy cells. This multi-parameter approach enables selective cancer treatment without the broad toxicity of conventional therapies.
Solution Approach 2:
The patent segments the treatment approach into three distinct domains: biophysical changes (bioelectrical features), structural changes (cytoskeleton, organelle morphology), and physiological changes (gene expression, metabolism). This segmentation allows targeted intervention in specific cancer cell characteristics while maintaining normal cell function, thereby reducing overall toxicity.
2Reliability
If current cancer treatments target specific proteins or pathways, then some cancer cells are treated, but the scope is limited and treatment resistance develops
Solution Approach 1:
The patent implements universality by developing a multi-domain treatment framework that simultaneously addresses biophysical, structural, and physiological aspects of cancer cells. This multi-functional approach treats various cancer types and stages through unified mechanisms, enhancing biological scope and reducing the likelihood of treatment resistance compared to single-target therapies.
Solution Approach 2:
The patent merges previously separate treatment domains (bioelectrical modulation, structural reorganization, physiological reprogramming) into an integrated treatment system. This combination creates synergistic effects that broaden the treatment scope and improve effectiveness across different cancer types while minimizing the development of resistance.
3Reliability
If cancer cells are treated with conventional methods, then tumor growth is inhibited, but metastasis is not effectively addressed
Solution Approach 1:
The patent applies preliminary action by modulating biophysical and structural parameters of cancer cells before they can initiate metastasis. By pre-establishing hyperpolarized membrane potentials and reorganized cytoskeletons, the treatment prevents metastatic behaviors from developing, rather than merely treating metastasis after it occurs, thereby effectively reducing metastatic potential.
Solution Approach 2:
The patent uses biophysical parameters (membrane potential, ion channel activity) and structural parameters (cytoskeleton organization) as intermediary mechanisms that mediate between treatment interventions and the final outcome of reduced metastasis. These intermediaries translate external treatment signals into internal cellular changes that inhibit metastatic processes.
Data Source
AI summary
Provided herein are systems and methods for decreasing metastatic potential of cells and/or adjusting biological functioning of an entity by effecting a change in at least one biophysical (e.g. bioelectrical) feature, at least one structural feature, and at least one physiological feature of cells. The systems and methods can include administration of biofield therapy, and in some embodiments alter expression of genes associated with the changes in bioelectrical, structural, and/or physiological features.